Prevention of the cytokine storm in COVID-19.
作者信息
Wright David J M
机构信息
Emeritus Reader in Medical Microbiology, Imperial College London, London SW7 7BU, UK.
出版信息
Lancet Infect Dis. 2021 Jan;21(1):25-26. doi: 10.1016/S1473-3099(20)30376-5. Epub 2020 May 7.
Abstract
摘要
相似文献
1
Prevention of the cytokine storm in COVID-19.新型冠状病毒肺炎细胞因子风暴的预防
Lancet Infect Dis. 2021 Jan;21(1):25-26. doi: 10.1016/S1473-3099(20)30376-5. Epub 2020 May 7.
2
COVID 19: in the eye of the cytokine storm.新冠病毒 19：处于细胞因子风暴之中
Eur Heart J. 2021 Jan 7;42(2):150-151. doi: 10.1093/eurheartj/ehaa1005.
3
COVID-19 cytokine storm: what is in a name?新冠病毒细胞因子风暴：名称中有何含义？
Ann Rheum Dis. 2021 Jan;80(1):3-5. doi: 10.1136/annrheumdis-2020-219448. Epub 2020 Nov 17.
4
Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.COVID-19 患者经体外血液净化治疗后，细胞因子风暴得到成功控制，病情得到恢复。
Int J Infect Dis. 2020 Jul;96:618-620. doi: 10.1016/j.ijid.2020.05.065. Epub 2020 May 26.
5
Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the Caused by SARS-CoV-2?己酮可可碱和别嘌呤醇：预防 SARS-CoV-2 引起的疾病的潜在药物？
Curr Pharm Des. 2020;26(35):4515-4521. doi: 10.2174/1381612826666200811180232.
6
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
7
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.严重急性呼吸综合征冠状病毒 2 感染：细胞因子在 COVID-19 疾病中的作用。
Cytokine Growth Factor Rev. 2020 Aug;54:62-75. doi: 10.1016/j.cytogfr.2020.06.001. Epub 2020 Jun 2.
8
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺，增加白细胞介素-1 水平，导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
9
Cytokine storm and the prospects for immunotherapy with COVID-19.细胞因子风暴与 COVID-19 免疫治疗的前景。
Cleve Clin J Med. 2020 Jun 30;87(7):389-393. doi: 10.3949/ccjm.87a.ccc008.
10
Calming the cytokine storm in COVID-19.平息新冠病毒肺炎中的细胞因子风暴
Nat Med. 2021 Oct;27(10):1674-1675. doi: 10.1038/s41591-021-01500-9.
引用本文的文献
1
Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits.药物诱导自噬通过降解免疫蛋白酶体亚基减少巨噬细胞中的炎症。
PLoS Biol. 2024 Mar 6;22(3):e3002537. doi: 10.1371/journal.pbio.3002537. eCollection 2024 Mar.
2
Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets.天然植物作为 SARS-CoV-2 靶点潜在抑制剂的最新进展。
Pharm Biol. 2023 Dec;61(1):1186-1210. doi: 10.1080/13880209.2023.2241518.
3
Common Coagulopathies Associated With COVID-19 Patients.与新冠病毒感染患者相关的常见凝血障碍
Cureus. 2023 Apr 24;15(4):e38067. doi: 10.7759/cureus.38067. eCollection 2023 Apr.
4
Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis.METRNβ 作为新型生物标志物用于评估 2019 年冠状病毒病严重程度和预后。
Front Immunol. 2023 Jan 31;14:1111920. doi: 10.3389/fimmu.2023.1111920. eCollection 2023.
5
Zymosan Particle-Induced Hemodynamic, Cytokine and Blood Cell Changes in Pigs: An Innate Immune Stimulation Model with Relevance to Cytokine Storm Syndrome and Severe COVID-19.酵母聚糖颗粒诱导猪的血液动力学、细胞因子和血细胞变化：一种与细胞因子风暴综合征和严重 COVID-19 相关的固有免疫刺激模型。
Int J Mol Sci. 2023 Jan 6;24(2):1138. doi: 10.3390/ijms24021138.
6
Oligomerization-Dependent Beta-Structure Formation in SARS-CoV-2 Envelope Protein.SARS-CoV-2 包膜蛋白寡聚依赖性的β结构形成。
Int J Mol Sci. 2022 Oct 31;23(21):13285. doi: 10.3390/ijms232113285.
7
Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review.2019冠状病毒病诊断与冠状动脉血栓形成之间的关联：一项叙述性综述
Biomedicines. 2022 Mar 18;10(3):702. doi: 10.3390/biomedicines10030702.
8
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.从进化角度看血管防御、止血、癌症和血小板生物学。
Cancer Metastasis Rev. 2022 Mar;41(1):147-172. doi: 10.1007/s10555-022-10019-5. Epub 2022 Jan 12.
9
Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses.新冠病毒感染中的抗病毒免疫：从保护性反应到有害反应
Microorganisms. 2021 Dec 13;9(12):2578. doi: 10.3390/microorganisms9122578.
10
Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?皮肤科药物治疗 2019 年冠状病毒病的再利用：科学还是虚构？
Clin Dermatol. 2021 May-Jun;39(3):430-445. doi: 10.1016/j.clindermatol.2021.01.020. Epub 2021 Feb 2.
本文引用的文献
1
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.迫切需要开展针对新型冠状病毒肺炎的抗肿瘤坏死因子疗法试验。
Lancet. 2020 May 2;395(10234):1407-1409. doi: 10.1016/S0140-6736(20)30858-8. Epub 2020 Apr 9.
2
The Jarisch-Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Cases and Our Understanding of Pathogenesis.抗生素治疗螺旋体感染后的雅里希-赫克斯海默反应：近期病例回顾及我们对发病机制的理解
Am J Trop Med Hyg. 2017 Jan 11;96(1):46-52. doi: 10.4269/ajtmh.16-0434. Epub 2016 Oct 24.
3
The effect of antibody against TNF alpha on cytokine response in Jarisch-Herxheimer reactions of louse-borne relapsing fever.抗TNFα抗体对虱传回归热Jarisch-Herxheimer反应中细胞因子反应的影响。
QJM. 1997 Mar;90(3):213-21. doi: 10.1093/qjmed/90.3.213.
4
Meptazinol diminishes the Jarisch-Herxheimer reaction of relapsing fever.美普他酚可减轻回归热的赫氏反应。
Lancet. 1983 Apr 16;1(8329):835-9. doi: 10.1016/s0140-6736(83)91384-3.
Zotero 插件